Einav Tayeb-Fligelman

807 total citations
10 papers, 546 citations indexed

About

Einav Tayeb-Fligelman is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Einav Tayeb-Fligelman has authored 10 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Physiology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Einav Tayeb-Fligelman's work include Alzheimer's disease research and treatments (4 papers), Oral microbiology and periodontitis research (2 papers) and RNA modifications and cancer (2 papers). Einav Tayeb-Fligelman is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Oral microbiology and periodontitis research (2 papers) and RNA modifications and cancer (2 papers). Einav Tayeb-Fligelman collaborates with scholars based in Israel, United States and Germany. Einav Tayeb-Fligelman's co-authors include Meytal Landau, Orly Tabachnikov, Jacques‐Philippe Colletier, M.R. Sawaya, Nicolas Coquelle, Nir Salinas, Raz Jelinek, Dieter Willbold, M.G. Deshmukh and Ravit Malishev and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Einav Tayeb-Fligelman

10 papers receiving 543 citations

Peers

Einav Tayeb-Fligelman
Cuihua Hu China
Alex Macmillan Australia
Nawal K. Khadka United States
Lindsey M. Gottler United States
Pan Fang China
Cuihua Hu China
Einav Tayeb-Fligelman
Citations per year, relative to Einav Tayeb-Fligelman Einav Tayeb-Fligelman (= 1×) peers Cuihua Hu

Countries citing papers authored by Einav Tayeb-Fligelman

Since Specialization
Citations

This map shows the geographic impact of Einav Tayeb-Fligelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Einav Tayeb-Fligelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Einav Tayeb-Fligelman more than expected).

Fields of papers citing papers by Einav Tayeb-Fligelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Einav Tayeb-Fligelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Einav Tayeb-Fligelman. The network helps show where Einav Tayeb-Fligelman may publish in the future.

Co-authorship network of co-authors of Einav Tayeb-Fligelman

This figure shows the co-authorship network connecting the top 25 collaborators of Einav Tayeb-Fligelman. A scholar is included among the top collaborators of Einav Tayeb-Fligelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Einav Tayeb-Fligelman. Einav Tayeb-Fligelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lu, Jiahui, P. Ge, M.R. Sawaya, et al.. (2023). Cryo-EM structures of the D290V mutant of the hnRNPA2 low-complexity domain suggests how D290V affects phase separation and aggregation. Journal of Biological Chemistry. 300(2). 105531–105531. 4 indexed citations
2.
Salinas, Nir, Einav Tayeb-Fligelman, Massimo Sammito, et al.. (2021). The amphibian antimicrobial peptide uperin 3.5 is a cross-α/cross-β chameleon functional amyloid. Proceedings of the National Academy of Sciences. 118(3). 48 indexed citations
3.
Tayeb-Fligelman, Einav, Nir Salinas, Orly Tabachnikov, & Meytal Landau. (2020). Staphylococcus aureus PSMα3 Cross-α Fibril Polymorphism and Determinants of Cytotoxicity. Structure. 28(3). 301–313.e6. 52 indexed citations
4.
Salinas, Nir, et al.. (2019). Structural Insights into Curli CsgA Cross-β Fibril Architecture Inspire Repurposing of Anti-amyloid Compounds as Anti-biofilm Agents. PLoS Pathogens. 15(8). e1007978–e1007978. 79 indexed citations
5.
Malishev, Ravit, et al.. (2018). Reciprocal Interactions between Membrane Bilayers and S. aureus PSMα3 Cross-α Amyloid Fibrils Account for Species-Specific Cytotoxicity. Journal of Molecular Biology. 430(10). 1431–1441. 33 indexed citations
6.
Tayeb-Fligelman, Einav, Orly Tabachnikov, M.R. Sawaya, et al.. (2017). The cytotoxic Staphylococcus aureus PSMα3 reveals a cross-α amyloid-like fibril. Science. 355(6327). 831–833. 240 indexed citations
7.
Reinstein, Eyal, Ana Gutiérrez‐Fernández, Shay Tzur, et al.. (2016). Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C. European Journal of Human Genetics. 24(12). 1792–1796. 33 indexed citations
8.
Tayeb-Fligelman, Einav & Meytal Landau. (2016). X-Ray Structural Study of Amyloid-Like Fibrils of Tau Peptides Bound to Small-Molecule Ligands. Methods in molecular biology. 1523. 89–100. 3 indexed citations
9.
Rayyan, Amal Abu, Kathy Ushakov, Liat Amir-Zilberstein, et al.. (2015). The GPSM2/LGN GoLoco motifs are essential for hearing. Mammalian Genome. 27(1-2). 29–46. 30 indexed citations
10.
Reinstein, Eyal, Katia Orvin, Einav Tayeb-Fligelman, et al.. (2015). Mutations inTAX1BP3Cause Dilated Cardiomyopathy with Septo-Optic Dysplasia. Human Mutation. 36(4). 439–442. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026